Effects of regular yoga practice in individuals with and without metabolic syndrome

Not Applicable

Completed

• Conditions: Metabolic syndrome; Metabolic and Endocrine - Metabolic disorders

• Registration Number: ACTRN12613000816752
• Lead Sponsor: Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-07-24
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 184

Inclusion Criteria

For all eligible participants, they should be
1) Chinese national and able to communicate in Cantonese
2) aged 18 or above
3) physically and mentally capable of practicing yoga safely

The current study will include both participants with and without metabolic syndrome. The researcher will categorize the participants into either with metabolic syndrome group or without metabolic syndrome group based on the WC, blood pressure, TG, HDL-C, and FBG at baseline assessment of the participants.

Participants will be categorized participants to metabolic syndrome group if they meet at least three of the revised NCEP-ATP III clinical diagnosis criteria for Asian populations (Grundy et al., 2005):
1) Waist circumference (WC): greater than or equal to 90 cm in men; greater than or equal to 80 cm in women
2) Triglyceride (TG): greater than or equal to 150 mg/dL or on drug treatment for elevated TG
3) High-density lipoprotein cholesterol (HDL-C): less than 40 mg/dL in men, less than 50 mg/dL in women or on drug treatment for reduced HDL-C
4) Systolic blood pressure (SBP): greater than or equal to 130 mmHg or diastolic blood pressure (DBP) greater than or equal to 85 mmHg or on antihypertensive drug treatment in a patient with a history of hypertension
5) Fasting blood glucose (FBG): greater than 110 mg/dL or on drug treatment for elevated glucose

For those who do not meet at least 3 of the above criteria, they will be categorized in a non-metabolic syndrome group.

Exclusion Criteria

1) Regular participation of (> 1/week) yoga for last 3 months or concurrent use of yoga, Qigong or meditation
2) Pregnancy or breast feeding
3) Anticipate any planned life stressors (moving, divorce, changing job, etc.), shift work, or transcontinental travel during the intervention
4) Undergo any other concurrent nonpharmacological treatment of MetSyn
5) Chronic illnesses: cancer, kidney disease, cirrhosis, rheumatologic diseases, or chronic inflections
6) Current major psychiatric illnesses, cognitive impairment, or substance abuse
7) Concurrent enrollment in any other studies, experimental therapies, or blinded treatments

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
In this study, the instruments with established validity and reliability will be used to determine each outcome. <br><br>A. Outcomes related to metabolic risk factors:<br>Outcome 1.Blood pressure: <br>Blood pressure measurements will be measured in seated position according to the American Heart Association Scientific Statement (Pickering et al., 2005). The average of the second and third systolic and diastolic pressure reading will be used in the analyses.[At baseline and post-intervention (12 weeks)];Outcome 2. Waist circumference (WC): <br>WC will be measured at the nearest 0.5 cm at the shortest point below the lower rib margin and the iliac crest.[At baseline and post-intervention (12 weeks)];Outcome 3. Fasting blood glucose (FBG)<br>FBG will obtained by taking blood samples from subjects and sent the samples to the laboratory for analysis.<br>[At baseline and post-intervention (12 weeks)]